References
- do Nascimento RG, Otoni KM. Histological and molecular classification of breast cancer: what do we know. Mastology 2020;30:1–8.
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021 May;71(3):209–49.
- Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019 Apr 15;144(8):1941–53.
- Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global Cancer in women: burden and trends. Cancer Epidemiol Biomarkers Prev 2017 Apr;26(4):444–57.
- Henry NL, Cannon-Albright LA. Breast cancer histologic subtypes show excess familial clustering. Cancer 2019 Sep 15;125(18):3131–8.
- Masood S. Breast cancer subtypes: morphologic and biologic characterization. Women's Health (Lond) 2016 Jan;12(1):103–19.
- Henry NL, Shah PD, Haider I, Freer PE, Jagsi R, and Sabel MS. Cancer of the breast. In: Editor(s): Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, editors. Abeloff's clinical oncology. Amsterdam: Elsevier. 6th ed. 2020. p.1560–1603.e12.
- Downs-Kelly E, Nayeemuddin KM, Albarracin C, Wu Y, Hunt KK, Gilcrease MZ. Matrix-producing carcinoma of the breast: an aggressive subtype of metaplastic carcinoma. Am J Surg Pathol 2009 Apr;33(4):534–41.
- Song Y, Liu X, Zhang G, Song H, Ren Y, He X, et al. Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators. World J Surg Oncol 2013;11(1):1–9.
- Pezzi CM, Patel-Parekh L, Cole K, Franko J, Klimberg VS, Bland K. Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base. Ann Surg Oncol 2007 Jan;14(1):166–73.
- Bae SY, Lee SK, Koo MY, Hur SM, Choi MY, Cho DH, et al. The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients. Breast Cancer Res Treat 2011;126(2):471–8.
- Aydiner A, Sen F, Tambas M, Ciftci R, Eralp Y, Saip P, et al. Metaplastic breast carcinoma versus triple-negative breast cancer: survival and response to treatment. Medicine 2015 Dec;94(52):e2341.
- Okushiba S, Minagawa H, Shimizu M, Ambo Y, Kaji M, Omi M, et al. A case of spindle cell carcinoma of the breast––long survival achieved by multiple surgical treatment. Breast Cancer 2001;8(3):238–42.
- Alexander JS, Hashmi H, Reynolds SB. Debilitating metastatic spindle cell carcinoma of the breast. Cureus 2019;11(1):e3864.
- Kitada M, Hayashi S, Matsuda Y, Ishibashi K, Oikawa K, Miyokawa N. Spindle cell carcinoma of the breast as complex cystic lesion: a case report. Cancer Biol Med 2014 Jun;11(2):130–3.
- Cho SN, Kim YS, Kim KC. Very rare case of spindle cell carcinoma of breast in male. J Breast Dis 2014;2(2):69–72.
- Ünal B, Erdogan G, Karaveli FŞ. Step by step approach to rare breast lesions containing spindle cells. Springerplus 2015;4:678.
- Alaoui MH, Abbad F, Rais H, Asmouki H, Soumani A, Khouchani M, et al. Rare variant of metaplastic carcinoma of the breast: a case report and review of the literature. J Med Case Rep 2018 Feb 21;12(1):43.
- Bauer TW, Rostock RA, Eggleston JC, Baral E. Spindle cell carcinoma of the breast: four cases and review of the literature. Hum Pathol 1984;15:147–52.
- Zhang Y, Lv F, Yang Y, Qian X, Lang R, Fan Y, et al. Clinicopathological features and prognosis of metaplastic breast carcinoma: experience of a major Chinese cancer center. PLoS One 2015;10(6):e0131409.
- Moten AS, Jayarajan SN, Willis AI. Spindle cell carcinoma of the breast: a comprehensive analysis. Am J Surg 2016;211(4):716–21.
- Khan HN, Wyld L, Dunne B, Lee AHS, Pinder SE, Evans AJ, et al. Spindle cell carcinoma of the breast: a case series of a rare histological subtype. Eur J Surg Oncol 2003;29(7):600–3.